The GENetic Frontotemporal Dementia Initiative (GENFI): a new multi-centre platform for the study of frontotemporal lobar degeneration

Martin Rossor (MRC), Giovanni B. Frisoni (MDS), Mario Masellis (CIHR)

Recent advances in molecular biology and neuropathology of frontotemporal lobar degeneration (FTLD) have yet to be translated into effective, disease-modifying therapies. Further progress toward this goal will depend on largescale collaborative efforts that harness resources and expertise across specialist centres. The proposed programme will develop and evaluate the feasibility of a platform for mounting future large-scale natural history studies of FTLD and for conducting clinical trials of disease-modifying interventions.

Inform yourself on our website cookie-free. However, we would be pleased if you would allow us to use statistical cookies. Your browser settings regarding cookies are currently as follows:
More information can be found in our Privacy policy.